Comparison of glucose derivatives effects on cartilage degradation

BMC Musculoskelet Disord. 2010 Jul 15:11:162. doi: 10.1186/1471-2474-11-162.

Abstract

Background: Glucosamine (GlcN) is a well-recognized candidate for treatment of osteoarthritis. However, it is currently used in derivative forms, such as glucosamine-hydrochloride (GlcN-HCl) or glucosamine sulfate (GlcN-S). However, the molecular mode of action remains unclear. In this study, we compared the effects of Glucose (Glc), Glucuronic acid (GlcA), Glucosamine hydrochloride (GlcN-HCl) and Glucosamine sulfate (GlcN-S) on cartilage degradation.

Methods: Porcine cartilage explants were co-cultured with recombinant human IL-1beta and each tested substance for 3 days. HA, s-GAG and MMP-2 releases to media were measured using ELISA, dye-binding assay and gelatin zymography, respectively. Similar studies were performed in a human articular chondrocytes (HAC) monolayer culture, where cells were co-treated with IL-1beta and each reagent for 24 hours. Subsequently, cells were harvested and gene expression measured using RT-PCR. All experiments were carried out in triplicate. Student's t-tests were used for statistical analysis.

Results: In cartilage explants treated with IL-1beta, GlcN-S had the highest chondroprotective activity of all four chemicals as shown by the inhibition of HA, s-GAG and MMP-2 released from cartilage. The anabolic (aggrecan core protein; AGG, SOX9) and catabolic (MMP-3, -13) genes in HACs treated with IL-1beta and with/without chemicals were studied using RT-PCR. It was found that, GlcN-HCl and GlcN-S could reduce the expression of both MMP-3 and -13 genes. The IL-1beta induced-MMP-13 gene expression was decreased maximally by GlcN-S, while the reduction of induced-MMP-3 gene expression was greatest with GlcN-HCl. Glc and GlcA reversed the effect of IL-1beta on the expression of AGG and SOX9, but other substances had no effect.

Conclusion: This study shows that glucosamine derivatives can alter anabolic and catabolic processes in HACs induced by IL-1beta. GlcN-S and GluN-HCl decreased induced MMP-3 and -13 expressions, while Glc and GlcA increased reduced-AGG and SOX9 expression. The chondroprotective study using porcine cartilage explant showed that GlcN-S had the strongest effect.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aggrecans / metabolism
  • Animals
  • Cartilage Diseases / drug therapy
  • Cartilage Diseases / metabolism
  • Cartilage Diseases / pathology
  • Cartilage, Articular / drug effects*
  • Cartilage, Articular / metabolism
  • Cartilage, Articular / pathology
  • Cells, Cultured
  • Coculture Techniques
  • Glucosamine / chemistry*
  • Glucosamine / pharmacology*
  • Glucosamine / therapeutic use
  • Glucose / analogs & derivatives*
  • Glucose / pharmacology*
  • Glucose / therapeutic use
  • Glucuronic Acid / pharmacology
  • Glucuronic Acid / therapeutic use
  • Glycosaminoglycans / metabolism
  • Humans
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / physiology
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / physiology
  • Osteoarthritis / drug therapy
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology
  • SOX9 Transcription Factor / metabolism
  • Sus scrofa

Substances

  • Aggrecans
  • Glycosaminoglycans
  • Inflammation Mediators
  • Interleukin-1beta
  • SOX9 Transcription Factor
  • SOX9 protein, human
  • Glucuronic Acid
  • Glucose
  • Glucosamine